Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies.
about
Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications.Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.Initial treatment of CLL: integrating biology and functional status.Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.Bone marrow stroma-induced resistance of chronic lymphocytic leukemia cells to arsenic trioxide involves Mcl-1 upregulation and is overcome by inhibiting the PI3Kδ or PKCβ signaling pathwaysDisruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II StudyUlocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathwayPreclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the tradeOfatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune CharacteristicsTargeting PI3Kδ: emerging therapy for chronic lymphocytic leukemia and beyond.Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.Circulating Tfh1 (cTfh1) cell numbers and PD1 expression are elevated in low-grade B-cell non-Hodgkin's lymphoma and cTfh gene expression is perturbed in marginal zone lymphoma.Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia.CD84 mediates CLL-microenvironment interactions.GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets.A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression.
P2860
Q30248557-2F06F238-2EE1-49AA-955F-34C54EE447C6Q33708995-2D9B0F57-D97A-4C76-A4C9-F3DDB545BA8CQ36219647-21BA5AD4-01DC-44A4-B02E-35CB0CAA6CF6Q36544769-1ECC8716-1B83-436E-8253-301B6B4C932CQ36689108-3B2A6AF9-53BE-4914-A42B-24B9997738BDQ36759124-4893B88A-EAEE-4E5F-B8CD-3210E4422D19Q36771955-888662F9-7BFF-4A02-8A31-30A60AB7B07AQ36867755-85FF9B18-0EED-40F4-808A-CEC5762F2007Q37427107-9F122323-064C-4BAC-9EB3-D56E160F1423Q38375141-3239B811-D38B-405D-B4E6-7D3EC58958AEQ39770651-3ED261D0-3CA0-4BE0-A329-8424EC0DC873Q45083622-C864BD6B-A3F6-4E24-A0AB-F81AD900E510Q48090885-C1D9F2F3-E272-4FC2-8055-F229AAF2B5C7Q48321396-0740604C-DA78-465A-ADD3-6E02B4465301Q50062136-975EA2BA-F9FD-457A-9E9F-4110447DBF36Q51121235-FD075A73-246A-45EE-986D-0D0BEB0402EBQ51620105-E036D057-9742-4F7D-A570-041DEC7F64A3Q55142863-97C6217E-B1CC-45C7-8A4F-5AB74BF7DE4FQ55261210-CBC299A0-36ED-41E8-829C-DE5E06A5C6F9
P2860
Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Microenvironment dependency in ...... is for new targeted therapies.
@ast
Microenvironment dependency in ...... is for new targeted therapies.
@en
Microenvironment dependency in ...... is for new targeted therapies.
@nl
type
label
Microenvironment dependency in ...... is for new targeted therapies.
@ast
Microenvironment dependency in ...... is for new targeted therapies.
@en
Microenvironment dependency in ...... is for new targeted therapies.
@nl
prefLabel
Microenvironment dependency in ...... is for new targeted therapies.
@ast
Microenvironment dependency in ...... is for new targeted therapies.
@en
Microenvironment dependency in ...... is for new targeted therapies.
@nl
P1476
Microenvironment dependency in ...... is for new targeted therapies.
@en
P2093
Elisa ten Hacken
Jan A Burger
P304
P356
10.1016/J.PHARMTHERA.2014.07.003
P577
2014-07-19T00:00:00Z